Supplements
Effectiveness is low due to early promise (2.6kg loss in small 12-week trial at 1mg/day oral) not replicated in larger phase IIb (failed commercial viability), with no strong human evidence for fat loss claims post-2007. Safety tempered by clean trial data (no hGH-like sides, safe up to 500 subjects) but downgraded for FDA compounding risks (immunogenicity/injection) and real-world sterility recalls/adverse reports. Quality minimal as unregulated research chemical lacks certifications, transpare
AOD-9604 lacks robust evidence for weight loss after failing phase IIb trials and is not FDA-approved. While trials showed good safety, real-world risks from unregulated injectables and FDA warnings make it unsuitable. Avoid; opt for proven therapies.